North America Smoking Cessation Aids Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes, and Others) and End User (Hospital Pharmacies, Online Channel, Retail Pharmacies, and Other End Users)
Market Introduction
Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do not. Counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, may be used to help a person quit smoking. They are regulated through the FDA’s Center for Drug Evaluation and Research, which ensures that the products are safe and effective and that their benefits outweigh any known associated risks.
Get more information on this report :
Market Overview and Dynamics
The North America smoking cessation aids market is expected to reach US$ 25,126.27 million in 2028 from US$ 9,049.15 million in 2021; it is estimated to grow at a CAGR of 15.7% from 2021 to 2028. Key factors that are driving the growth of this market are rising addiction toward tobacco smoking and increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.
The smoking of tobacco is proven to be dangerous in all forms as it can lead to chronic health conditions, preventable diseases, deaths, and disabilities. According to the World Health Organization (WHO), smoking-related disorders result in about 435,000 deaths per year in the US, which equals to around 1 in 5 of the total deaths in the country. Therefore, prevalence of tobacco smoking is high across various countries in the North America that drives the growth of the smoking cessation aids market. The government and nongovernment organizations worldwide are coming forward and launching campaigns to provide awareness and undertake measures to curb the diseases caused due to smoking and tobacco consumption. The measures are taken to reduce the economic and health burden caused due to cigarette smoking in countries worldwide. For instance, every year on May 31st, the WHO along with its global partners celebrate World No Tobacco Day (WNTD) to spread education and awareness regarding the harmful and deadly effects of tobacco and second-hand smoke exposure. Initiatives undertaken on this day mainly aim to discourage the consumption of tobacco in any form and educate people regarding the availability of aids that assist in smoking cessation. The launch of anti-smoking campaigns is organized on global, national, and regional levels worldwide. The governments of various countries have increased excise duties and taxes on tobacco-based cigarettes and cigars to reduce its affordability, thus consumption among common populace. In addition, numerous governments have legalized the use of e-cigarettes as a smoking cessation aid under licensed sales channels to prevent people from opting conventional cigarettes. Thus, the increasing efforts undertaken by governments as well as non-profit and nongovernment organizations to promote the use of smoking cessation aids and reduce the number of smoking populations boost the growth of the market.
The North American region is highly affected due to the outbreak of the COVID-19 pandemic. Researchers from Stanford University show that teenagers and young adults of age 13–24 years, who use e-cigarettes, are five times more inclined to be diagnosed with COVID-19 than their non-vaping peers. As per the WHO, they have been evaluating new research constantly, the new research states that there is positive relation between tobacco use, nicotine use helping COVID-19 patients to get well. For increasing risk for COVID-19, smoking is the major cause of underlying health conditions. However, there is currently insufficient information to confirm any link between tobacco or nicotine in the prevention or treatment of COVID-19. Hence, COVID-19 pandemic does not show significant impact on smoking cessation aids market.
Key Market Segments
Based on product, the North America smoking cessation aids market is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. In 2021, the electronic cigarettes segment is likely to hold the largest share of the market and is expected to grow at the fastest rate in the coming years.
Based on end user, the North America smoking cessation aids market is segmented into hospital pharmacies, online channel, retail pharmacies, and other end users. The retail pharmacies segment is likely to hold the largest share of the market in 2021, whereas the online channel segment is anticipated to register the highest CAGR of the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the North America smoking cessation aids market are the United Nations Office of Drugs and Crime (UNODC), American Addictions Center (AAC), and United Nations Educational, Scientific and Cultural Organization (UNESCO).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of North America smoking cessation aids market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the North America smoking cessation aids market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America smoking cessation aids market.
NORTH AMERICA SMOKING CESSATION AIDS MARKET SEGMENTATION
By Product
- Nicotine Replacement Therapy
- Drugs
- Electronic Cigarettes
- Other End Users
By End User
- Hospital Pharmacies
- Online Channel
- Retail Pharmacies
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Pfizer Inc.
- GlaxoSmithKline plc.
- Dr. Reddy's Laboratories
- Johnson and Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Juul Labs
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Smoking Cessation Aids Market – By Product
1.3.2 North America Smoking Cessation Aids Market – By End User
1.3.3 North America Smoking Cessation Aids Market – By Country
2. Smoking Cessation Aids Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Smoking Cessation Aids Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinions
5. Smoking Cessation Aids Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Addiction of Tobacco Smoking
5.1.2 Increasing Number of Campaigns to Reduce Smoking and Tobacco Dependence
5.2 Market Restraints
5.2.1 Steeping Costs for Development of Nicotine Replacement Therapies
5.3 Future Trends
5.3.1 Introduction of New Smoking Cessation Aids
5.4 Impact Analysis
6. Smoking Cessation Aids Market – North America Analysis
6.1 North America Smoking Cessation Aids Market Revenue Forecast and Analysis
7. Smoking Cessation Aids Market Analysis – By Product
7.1 Overview
7.2 Smoking Cessation Aids Market Revenue Share, by Product (2021 and 2028)
7.3 Nicotine Replacement Therapy
7.3.1 Overview
7.3.2 Nicotine Replacement Therapy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Drugs
7.4.1 Overview
7.4.2 Drugs: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Electronic Cigarettes
7.5.1 Overview
7.5.2 Electronic Cigarettes: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
8. Smoking Cessation Aids Market Analysis – By End User
8.1 Overview
8.2 Smoking Cessation Aids Market Share, by End User, 2021 and 2028, (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Online Channel
8.4.1 Overview
8.4.2 Online Channel: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Retail Pharmacies
8.5.1 Overview
8.5.2 Retail Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Other End Users
8.6.1 Overview
8.6.2 Other End Users: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
9. Smoking Cessation Aids Market – North America Analysis
9.1 North America: Smoking Cessation Aids Market
9.1.1 Overview
9.1.2 North America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
9.1.2.1 US: Smoking Cessation Aids Market– Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 US: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2 US: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.2.1.3 US: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.2.2 Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2 Canada: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)
9.1.2.2.3 Canada: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)
9.1.2.3 Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 Mexico: Smoking Cessation Aids Market, by Product – 2019–2028 (USD Million)
9.1.2.3.3 Mexico: Smoking Cessation Aids Market, by End User – 2019–2028 (USD Million)
10. Impact of COVID-19 Pandemic on North America Smoking Cessation Aids Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Pfizer Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GlaxoSmithKline plc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Dr. Reddy's Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Johnson and Johnson Services, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cipla Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Perrigo Company plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Glenmark
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NJOY
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Juul Labs
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. US: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 3. Canada Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 4. Canada Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Mexico Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 6. Mexico Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Organic Developments Done by Companies
Table 8. Inorganic Developments Done by Companies
Table 9. Glossary of Terms, Smoking Cessation Aids Market
LIST OF FIGURES
Figure 1. Smoking Cessation Aids Market Segmentation
Figure 2. Smoking Cessation Aids Market Segmentation, By Country
Figure 3. Smoking Cessation Aids Market Overview
Figure 4. Electronic Cigarettes Segment Held Largest Share of Smoking Cessation Aids Market
Figure 5. North America Smoking Cessation Aids Market – Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. Smoking Cessation Aids Market Impact Analysis of Drivers and Restraints
Figure 8. North America Smoking Cessation Aids Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Smoking Cessation Aids Market Revenue Share, by Product (2021 and 2028)
Figure 10. Nicotine Replacement Therapy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Drugs: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Electronic Cigarettes: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Smoking Cessation Aids Market Share, by End User, 2021 and 2028 (%)
Figure 15. Hospital Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Online Channel: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Retail Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Other End Users: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)
Figure 20. North America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)
Figure 21. US: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 22. Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 23. Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Impact of COVID-19 Pandemic in North American Country Markets
- Pfizer Inc.
- GlaxoSmithKline plc.
- Dr. Reddy's Laboratories
- Johnson and Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Juul Labs
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America smoking cessation aids market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America smoking cessation aids market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.